NCT01119313View on ClinicalTrials.gov

Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Atopic Eczema
Interventions
DRUG

LAS 41002

LAS 41002, once daily

DRUG

Active

Active, once daily

Trial Locations (1)

Unknown

Almirall Investigational Sites#1, Hamburg

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY